Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)

BACKGROUND: Etoposide (E) at 100 mg/m(2) combined with Cisplatin (P) at 20 mg/m(2) represents an induction 2-day regimen embedded in our clinical practice for patients with advanced GCT or TN at high risk of early death. We evaluated 24/7 Em-EP administration to a combined GCT-TN cohort at our Emerg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Chan Wah Hak, Charleen, Coyle, Christopher, Kocache, Arwa, Short, Dee, Sarwar, Naveed, Seckl, Michael J., Gonzalez, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6683367/
https://ncbi.nlm.nih.gov/pubmed/31382912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5968-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars